Huntington Hospital is pleased to announce that we have passed the Anticoagulation
(AC) Forum’s assessment test and will continue as an “Anticoagulation
Center of Excellence.” This designation, initially obtained in 2016, illustrates Huntington
Hospital’s strong commitment to providing the highest level of care
to patients taking antithrombotic medications.
“We are very proud to have passed the Anticoagulation Centers of
Excellence assessment,” said Gabriella Sherman, MD, MBA, Vice President,
Quality & Clinical Operations, Huntington Hospital. “We are
dedicated to actively participating in all aspects of our patients’
care to improve health outcomes and this recognition reflects our commitment
to community well-being.”
The Anticoagulation Centers of Excellence program helps healthcare professionals
provide the highest level of care and achieve the best possible outcomes
for patients on antithrombotic medications. The program offers a roadmap
to consistent, sustainable excellence in five key areas of patient care.
Because it successfully met the rigorous standards in each patient care
pillar, Huntington Hospital may be considered an Anticoagulation Center
of Excellence for two years.
“The assessment and educational resources on the AC Forum site helped
us streamline our operational performance, improve transition of care
and knowledge of drug therapy, and enhance patient education while learning
more about disease state management," said Tommy Mai, PharmD, Director
of Pharmacy Services, Huntington Hospital. “Congratulations to our
team for their hard work and dedication to achieve this important designation.”
An antithrombotic medication is a drug that reduces the formation of blood
clots (thrombi). Antithrombotics can be used therapeutically for prevention
or treatment of a dangerous blood clot (acute thrombus).
Huntington Hospital's Medication Therapy Management (MTM) Clinic is
operated by pharmacists and provides a variety of outpatient services
to patients, including anticoagulation management. The MTM Clinic monitors
and educates patients about blood-thinning medications such as warfarin
(Coumadin®), enoxaparin (Lovenox®), dabigatran (Pradaxa®),
rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Savaysa®)
through in-person visits in the clinic.
For more information, click
The Anticoagulation Forum is a multidisciplinary non-profit organization
that works to improve the quality of care for patients taking antithrombotic
medications. The AC Forum promotes the clinical application of evidence-based
practices, and provides education and networking opportunities for healthcare
professionals. To learn more about the program visit